Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-48.96M
↓ 48% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-33.03M
Historical baseline
PeriodValueYoY Change
TTM$-48.96M-0.6%
2024$-48.65M-7.1%
2023$-45.41M-13.8%
2022$-39.90M-38.3%
2021$-28.86M-51.2%
2020$-19.09M-14.4%
2019$-16.68M+2.2%
2018$-17.05M+33.4%
2017$-25.60M+36.2%
2016$-40.15M-